ArticleRadiology. Imaging cancer2026
Preoperative Contrast-enhanced CT Features Associated with Occult Lymph Node Metastasis in Early-Stage Solid Non-Small Cell Lung Cancer.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop and validate a contrast-enhanced CT-based prediction model for identifying occult lymph node metastasis (OLNM) in patients with early-stage non-small cell lung cancer (NSCLC), with the goal of supporting individualized lymph node dissection (LND) strategies. Materials and Methods This retrospective study included patients with preoperative clinical stage I-IIA (cT1-T2bN0M0) solid NSCLC who underwent lobectomy with systematic LND between January 2021 and April 2024. Univariable and multivariable logistic regression analyses were used to identify independent preoperative CT predictors of OLNM and to construct a nomogram. Model performance was assessed using the area under the receiver operating characteristic curve, and specificity was evaluated at a fixed sensitivity of 95%. Results Among 329 patients with solid NSCLC (median age, 65 years; IQR, 58-70 years; 168 male patients), 22.2% (73 of 329) had OLNM, including 47.9% (35 of 73) with N1 and 52.1% (38 of 73) with N2 metastases. Independent predictors of OLNM were a decreased inner margin ratio (odds ratio [OR], 0.02; 95% CI: 0.00, 0.10;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.